2021 NICE威廉亚洲博彩公司：艰难梭菌感染的抗菌药物处方（NG.199）

2021-07-23 英国国家卫生与临床优化研究所 NICE官网

2021年7月，英国国家卫生与临床优化研究所 (NICE)发布了艰难梭菌感染的抗菌药物处方威廉亚洲博彩公司，威廉亚洲博彩公司规定了社区和医院内成人，青少年以及年龄≥72h的婴幼儿艰难梭菌感染的抗菌药物处方策略，目的是优

中文标题：

英文标题：

NICE guideline [NG199]：Clostridioides difficile infection: antimicrobial prescribing

发布机构：

英国国家卫生与临床优化研究所

发布日期：

2021-07-23

简要介绍：

2021年7月，英国国家卫生与临床优化研究所 (NICE)发布了艰难梭菌感染的抗菌药物处方威廉亚洲博彩公司，威廉亚洲博彩公司规定了社区和医院内成人，青少年以及年龄≥72h的婴幼儿艰难梭菌感染的抗菌药物处方策略，目的是优化抗生素应用减少耐药性的产生。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=602661c0021a08c3, title=2021 NICE威廉亚洲博彩公司：艰难梭菌感染的抗菌药物处方（NG.199）, enTitle=NICE guideline [NG199]：Clostridioides difficile infection: antimicrobial prescribing, guiderFrom=NICE官网, authorId=0, author=, summary=2021年7月，英国国家卫生与临床优化研究所 (NICE)发布了艰难梭菌感染的抗菌药物处方威廉亚洲博彩公司，威廉亚洲博彩公司规定了社区和医院内成人，青少年以及年龄≥72h的婴幼儿艰难梭菌感染的抗菌药物处方策略，目的是优, cover=https://img.medsci.cn/2021731/1627737858949_2020535.jpg, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所（NICE，National Institute for Health and Clinical Excellence）是NHS的组织，设在伦敦和曼彻斯特。NICE成立于1999年4月1日，目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定威廉亚洲博彩公司，设定质量标准，管理国家数据库，为NHS、当地权威部门和其他组织提供威廉亚洲博彩公司。, copyright=0, guiderPublishedTime=Fri Jul 23 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年7月，英国国家卫生与临床优化研究所 (NICE)发布了艰难梭菌感染的抗菌药物处方威廉亚洲博彩公司，威廉亚洲博彩公司规定了社区和医院内成人，青少年以及年龄≥72h的婴幼儿艰难梭菌感染的抗菌药物处方策略，目的是优化抗生素应用减少耐药性的产生。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=3951, tagName=艰难梭菌)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=85, categoryName=威廉亚洲博彩公司 &解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3951, guiderKeyword=艰难梭菌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=威廉亚洲博彩公司 , guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12855, appHits=125, showAppHits=0, pcHits=756, showPcHits=12730, likes=0, shares=9, comments=8, approvalStatus=1, publishedTime=Sat Jul 31 22:52:04 CST 2021, publishedTimeString=2021-07-23, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Jul 31 21:25:39 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 18:27:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 NICE威廉亚洲博彩公司：艰难梭菌感染的抗菌药物处方（NG.199）.pdf)])

2021 NICE威廉亚洲博彩公司：艰难梭菌感染的抗菌药物处方（NG.199）.pdf

下载请点击：

评论区 (7)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1015217, encodeId=a4a0101521e8f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55495473976, createdName=ms7000000320809932, createdTime=Tue Sep 07 00:24:50 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010917, encodeId=6751101091e19, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/bed0b3f96f164c29bb553417bd81ed39/22e18fd963054cd8967b0fd25b4415eb.jpg, createdBy=a6474751676, createdName=bjszxyyyll, createdTime=Tue Aug 24 10:51:15 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010408, encodeId=333310104087b, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb6f4777421, createdName=kaixing1407, createdTime=Sun Aug 22 21:47:21 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008653, encodeId=97a21008653b0, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 11:43:46 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007688, encodeId=9a19100e688e9, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb725566333, createdName=ms1000001821280113, createdTime=Fri Aug 13 18:51:36 CST 2021, time=2021-08-13, status=1, ipAttribution=)]
2021-09-07 ms7000000320809932

好

112 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=1015217, encodeId=a4a0101521e8f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55495473976, createdName=ms7000000320809932, createdTime=Tue Sep 07 00:24:50 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010917, encodeId=6751101091e19, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/bed0b3f96f164c29bb553417bd81ed39/22e18fd963054cd8967b0fd25b4415eb.jpg, createdBy=a6474751676, createdName=bjszxyyyll, createdTime=Tue Aug 24 10:51:15 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010408, encodeId=333310104087b, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb6f4777421, createdName=kaixing1407, createdTime=Sun Aug 22 21:47:21 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008653, encodeId=97a21008653b0, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 11:43:46 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007688, encodeId=9a19100e688e9, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb725566333, createdName=ms1000001821280113, createdTime=Fri Aug 13 18:51:36 CST 2021, time=2021-08-13, status=1, ipAttribution=)]
2021-08-24 bjszxyyyll

学习了

114 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=1015217, encodeId=a4a0101521e8f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55495473976, createdName=ms7000000320809932, createdTime=Tue Sep 07 00:24:50 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010917, encodeId=6751101091e19, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/bed0b3f96f164c29bb553417bd81ed39/22e18fd963054cd8967b0fd25b4415eb.jpg, createdBy=a6474751676, createdName=bjszxyyyll, createdTime=Tue Aug 24 10:51:15 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010408, encodeId=333310104087b, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb6f4777421, createdName=kaixing1407, createdTime=Sun Aug 22 21:47:21 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008653, encodeId=97a21008653b0, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 11:43:46 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007688, encodeId=9a19100e688e9, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb725566333, createdName=ms1000001821280113, createdTime=Fri Aug 13 18:51:36 CST 2021, time=2021-08-13, status=1, ipAttribution=)]
2021-08-22 kaixing1407

学习了！

116 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=1015217, encodeId=a4a0101521e8f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55495473976, createdName=ms7000000320809932, createdTime=Tue Sep 07 00:24:50 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010917, encodeId=6751101091e19, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/bed0b3f96f164c29bb553417bd81ed39/22e18fd963054cd8967b0fd25b4415eb.jpg, createdBy=a6474751676, createdName=bjszxyyyll, createdTime=Tue Aug 24 10:51:15 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010408, encodeId=333310104087b, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb6f4777421, createdName=kaixing1407, createdTime=Sun Aug 22 21:47:21 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008653, encodeId=97a21008653b0, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 11:43:46 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007688, encodeId=9a19100e688e9, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb725566333, createdName=ms1000001821280113, createdTime=Fri Aug 13 18:51:36 CST 2021, time=2021-08-13, status=1, ipAttribution=)]
2021-08-17 DR.Fu SIR

好好

107 0 举报
[GetPortalCommentsPageByObjectIdResponse(id=1015217, encodeId=a4a0101521e8f, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55495473976, createdName=ms7000000320809932, createdTime=Tue Sep 07 00:24:50 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010917, encodeId=6751101091e19, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210824/bed0b3f96f164c29bb553417bd81ed39/22e18fd963054cd8967b0fd25b4415eb.jpg, createdBy=a6474751676, createdName=bjszxyyyll, createdTime=Tue Aug 24 10:51:15 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010408, encodeId=333310104087b, content=学习了！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb6f4777421, createdName=kaixing1407, createdTime=Sun Aug 22 21:47:21 CST 2021, time=2021-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008653, encodeId=97a21008653b0, content=好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Tue Aug 17 11:43:46 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007688, encodeId=9a19100e688e9, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=120, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb725566333, createdName=ms1000001821280113, createdTime=Fri Aug 13 18:51:36 CST 2021, time=2021-08-13, status=1, ipAttribution=)]
2021-08-13 ms1000001821280113

好

120 1 举报

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

消化威廉亚洲博彩公司

2021 NICE威廉亚洲博彩公司：艰难梭菌感染的抗菌药物处方（NG.199）

相关威廉亚洲博彩公司

拓展阅读

科室

工具

服务

消化威廉亚洲博彩公司

2021 NICE威廉亚洲博彩公司 ：艰难梭菌感染的抗菌药物处方（NG.199）

相关威廉亚洲博彩公司

拓展阅读

科室

工具

服务

2021 NICE威廉亚洲博彩公司：艰难梭菌感染的抗菌药物处方（NG.199）